Healthcare Infection Control Practices Advisory Committee (HICPAC), 26933 [2017-12122]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 111 / Monday, June 12, 2017 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–12060 Filed 6–9–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
asabaliauskas on DSKBBXCHB2PROD with NOTICES
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC), National
Center for Emerging and Zoonotic
Infectious Diseases (NCEZID) announces
a meeting of the aforementioned
committee:
Times and Dates:
9:00 a.m.–5:00 p.m., EDT, July 13, 2017
9:00 a.m.–12:00 p.m., EDT, July 14, 2017
Place: Centers for Disease Control and
Prevention, Global Communications
Center, Building 19, Auditorium B, 1600
Clifton Road NE., Atlanta, Georgia,
30329.
Status: Open to the public, limited
only by the space available. Time will
be available for public comment. The
public is welcome to submit written
comments in advance of the meeting.
Comments should be submitted in
writing by email to the contact person
listed below. The deadline for receipt is
June 30, 2017. All requests must contain
the name, address, and organizational
affiliation of the speaker, as well as the
topic being addressed. Written
comments should not exceed one singlespaced typed page in length and
delivered in 3 minutes or less. Members
of the public who wish to provide
public comments should plan to attend
the public comment session at the start
time listed. Please note that the public
comment period may end before the
time indicated on the agenda, following
the last call for comments. Written
comments received in advance of the
meeting will be included in the official
record of the meeting.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion (DHQP), the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
VerDate Sep<11>2014
17:28 Jun 09, 2017
Jkt 241001
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda
will include updates on CDC’s activities
for prevention of healthcare associated
infections (HAIs), an update on the
Division of Healthcare Quality
Promotion’s (DHQP) modeling
activities, updates on the Guideline for
Prevention of Infection in Neonatal
Intensive Care Unit (NICU) Patients and
the Guideline for Prevention of Infection
in Healthcare Personnel, and updates
from the following HICPAC workgroups:
The workgroup on antibiotic
stewardship principles for inclusion
into clinical practice guidelines, the
workgroup on updating the CDC
recommendation categorization scheme,
the workgroup on developing CDC
recommendations for products and
practices, and the National Healthcare
Safety Network (NHSN) Surveillance
Workgroup.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Erin Stone, M.A., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, l600 Clifton Road NE., Mailstop
A–07, Atlanta, Georgia 30329,
Telephone (404) 639–4045. Email:
hicpac@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–12122 Filed 6–9–17; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
26933
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP): Secondary
Review
In accordance with Section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces a meeting for the secondary
review of applications in response to
Funding Opportunity Announcements
(FOAs), CE17–003, Research Grants for
Preventing Violence and Violence
Related Injury (R01); and PHS 2016–02
Omnibus Solicitation of the NIH, CDC
FDA, and ACF for Small Business
Innovation Research Grant Applications
(Parent SBIR [R43/R44]).
Time and Date: 8:00 a.m.–5:00 p.m.,
EDT, July 18, 2017 (Closed).
Place: Teleconference.
Status: The meeting will be closed to
the public in accordance with
provisions set forth in Section
552b(c)(4) and (6), Title 5 U.S.C., and
the Determination of the Director,
Management Analysis and Services
Office, CDC, pursuant to Public Law 92–
463.
Matters for Discussion: The meeting
will include the secondary review,
discussion, and evaluation of
applications received in response to
FOAs ‘‘Research Grants for Preventing
Violence and Violence Related Injury
(R01)’’, CE17–003; and ‘‘PHS 2016–02
Omnibus Solicitation of the NIH, CDC
FDA, and ACF for Small Business
Innovation Research Grant Applications
(Parent SBIR [R43/R44])’’.
Contact Person for More Information:
Gwendolyn H. Cattledge, Ph.D.,
M.S.E.H., Deputy Associate Director for
Science, National Center for Injury
Prevention and Control, CDC, 4770
Buford Highway NE., Mailstop F–63,
Atlanta, Georgia 30341, Telephone (770)
488–1430.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
E:\FR\FM\12JNN1.SGM
12JNN1
]]>Agencies
[Federal Register Volume 82, Number 111 (Monday, June 12, 2017)]
[Notices]
[Page 26933]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-12122]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Healthcare Infection Control Practices Advisory Committee
(HICPAC)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC), National Center for Emerging and Zoonotic Infectious
Diseases (NCEZID) announces a meeting of the aforementioned committee:
Times and Dates:
9:00 a.m.-5:00 p.m., EDT, July 13, 2017
9:00 a.m.-12:00 p.m., EDT, July 14, 2017
Place: Centers for Disease Control and Prevention, Global
Communications Center, Building 19, Auditorium B, 1600 Clifton Road
NE., Atlanta, Georgia, 30329.
Status: Open to the public, limited only by the space available.
Time will be available for public comment. The public is welcome to
submit written comments in advance of the meeting. Comments should be
submitted in writing by email to the contact person listed below. The
deadline for receipt is June 30, 2017. All requests must contain the
name, address, and organizational affiliation of the speaker, as well
as the topic being addressed. Written comments should not exceed one
single-spaced typed page in length and delivered in 3 minutes or less.
Members of the public who wish to provide public comments should plan
to attend the public comment session at the start time listed. Please
note that the public comment period may end before the time indicated
on the agenda, following the last call for comments. Written comments
received in advance of the meeting will be included in the official
record of the meeting.
Purpose: The Committee is charged with providing advice and
guidance to the Director, Division of Healthcare Quality Promotion
(DHQP), the Director, National Center for Emerging and Zoonotic
Infectious Diseases (NCEZID), the Director, CDC, the Secretary, Health
and Human Services regarding (1) the practice of healthcare infection
prevention and control; (2) strategies for surveillance, prevention,
and control of infections, antimicrobial resistance, and related events
in settings where healthcare is provided; and (3) periodic updating of
CDC guidelines and other policy statements regarding prevention of
healthcare-associated infections and healthcare-related conditions.
Matters for Discussion: The agenda will include updates on CDC's
activities for prevention of healthcare associated infections (HAIs),
an update on the Division of Healthcare Quality Promotion's (DHQP)
modeling activities, updates on the Guideline for Prevention of
Infection in Neonatal Intensive Care Unit (NICU) Patients and the
Guideline for Prevention of Infection in Healthcare Personnel, and
updates from the following HICPAC workgroups: The workgroup on
antibiotic stewardship principles for inclusion into clinical practice
guidelines, the workgroup on updating the CDC recommendation
categorization scheme, the workgroup on developing CDC recommendations
for products and practices, and the National Healthcare Safety Network
(NHSN) Surveillance Workgroup.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Erin Stone, M.A., HICPAC,
Division of Healthcare Quality Promotion, NCEZID, CDC, l600 Clifton
Road NE., Mailstop A-07, Atlanta, Georgia 30329, Telephone (404) 639-
4045. Email: hicpac@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-12122 Filed 6-9-17; 8:45 am]
BILLING CODE 4163-18-P
